DSIP: Patient Information & Safety Notes
Also known as Delta sleep inducing peptide, DSIP peptide
Other names: delta-sleep-inducing-peptide, dsip-peptide
Delta sleep-inducing peptide (DSIP) is a naturally occurring neuropeptide first isolated from rabbit thalamus. It has been studied in limited clinical research for sleep modulation, but is NOT approved by the FDA and its mechanisms in humans are not well characterized.
In plain language
What Delta Sleep-Inducing Peptide is used for
- Studied in limited research for possible sleep-related effects
Taking this medicine
How it is administered
- Subcutaneous injection
Read before you decide
Risks and precautions
Risks and warnings
- Headache
- Injection site irritation
- Human safety profile not well established
Who should not take it
- Sleep apnea (precaution based on mechanism)
- Pregnancy or breastfeeding
Common questions
Patient questions
Is DSIP approved for sleep disorders?
No. DSIP is not FDA-approved for sleep disorders or any other condition. It is a research compound. Licensed providers can recommend evidence-based sleep treatments including behavioral therapies and FDA-approved medications.
Related medications
Explore treatment hubs
This information is educational — not medical advice.
This page is provided for general educational purposes and summarizes publicly available data from sources such as the U.S. Food & Drug Administration. It is not a substitute for the judgment of a licensed clinician and should not be used to start, stop, or change any medication. It may be incomplete or out of date, and individual circumstances vary. Always talk with your prescriber or pharmacist about your specific medications and health conditions. If you think you may have a medical emergency, call 911.
Sources & References
Learn more about where our data comes from and how we write and review medical content.